127 related articles for article (PubMed ID: 16125892)
1. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.
Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS
Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892
[TBL] [Abstract][Full Text] [Related]
2. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
[TBL] [Abstract][Full Text] [Related]
3. Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Acta Radiol; 2005 Apr; 46(2):148-54. PubMed ID: 15902889
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings: visual and quantitative analyses.
Kim SJ; Bae YT; Lee JS; Kim IJ; Kim YK
Ann Nucl Med; 2007 Jun; 21(3):145-50. PubMed ID: 17561585
[TBL] [Abstract][Full Text] [Related]
6. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
Buscombe JR; Cwikla JB; Holloway B; Hilson AJ
J Nucl Med; 2001 Jan; 42(1):3-8. PubMed ID: 11197976
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
[TBL] [Abstract][Full Text] [Related]
11. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
12. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
14. [Technetium-99m-tetrofosmin radionuclide mammography in the diagnosis of malignant breast tumors].
Jauković L
Vojnosanit Pregl; 2004; 61(1):35-40. PubMed ID: 15022387
[TBL] [Abstract][Full Text] [Related]
15. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
16. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
Chen J; Wu H; Zhou J; Hu J
Chin Med J (Engl); 2003 Apr; 116(4):620-4. PubMed ID: 12875735
[TBL] [Abstract][Full Text] [Related]
17. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y
Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
19. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
20. Detection of malignant breast tumours in dense breast tissue: results of 99mTc-tetrofosmin scintimammography related to surgery.
Bongers V; Borel Rinkes IH; Sie-Go DM; Pijnappel R; de Hooge P; van Rijk PP
Eur J Surg Oncol; 1999 Apr; 25(2):152-6. PubMed ID: 10218457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
